B

    BioLife Solutions Inc (BLFS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $37.07
    +0.69 (+1.90%)

    Market Cap: $1.78B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(21/40)
    Avg Surprise
    -35.75%
    Streak
    4 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.07
    Range$0.07 - $0.07
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.04-42.9%
    60d ago$0.07+0.0%
    30d ago$0.07+0.0%
    7d ago$0.07+0.0%
    Current$0.07
    Revenue Consensus
    $29M
    Range$29M - $30M
    5 analysts
    Dec 31, 2026
    EPS Consensus$0.10
    Range$0.10 - $0.10
    1 analysts
    Revenue Consensus
    $32M
    Range$32M - $34M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.10---
    Sep 26EST
    		-$0.07---
    Jun 26
    		$0.04$-0.01+500.00%Beat+112.1%
    Mar 26
    		$0.04$0.02+100.00%Beat+0.0%
    Dec 25
    		$0.04$-0.02+300.00%Beat+350.0%
    Sep 25
    		$0.04$-0.01+453.98%Beat+300.0%
    Jun 25
    		$-0.33$-0.02-1550.00%Miss-560.0%
    Mar 25
    		$0.04$-0.04+200.00%Beat+117.4%
    Dec 24
    		$-0.02N/A+71.78%Beat+92.4%
    Sep 24
    		$-0.02N/A+60.00%Beat+94.1%
    Jun 24
    		$-0.05$-0.09+44.44%Beat+79.2%
    Mar 24
    		$-0.23$-0.28+17.86%Beat+14.8%
    Dec 23
    		$-0.21$-0.27+22.22%Beat+81.7%
    Sep 23
    		$-0.34$-0.28-21.43%Miss-126.7%
    Jun 23
    		$-0.24$-0.18-33.33%Miss-84.6%
    Mar 23
    		$-0.27$-0.16-68.75%Miss-42.1%
    Dec 22
    		$-1.15$-0.17-576.47%Miss-210.8%
    Sep 22
    		$-0.15$-0.10-50.00%Miss+21.1%
    Jun 22
    		$-0.13$-0.15+13.33%Beat-8.3%
    Mar 22
    		$-0.19$-0.17-11.76%Miss-2000.0%
    Dec 21
    		$-0.37$-0.17-117.65%Miss-516.7%
    Sep 21
    		$-0.19$-0.09-111.11%Miss-850.0%
    Jun 21
    		$-0.12$0.03-500.00%Miss-1100.0%
    Mar 21
    		$0.01N/A+125.00%Beat-83.3%
    Dec 20
    		$-0.06$-0.02-200.00%Miss-400.0%
    Sep 20
    		$-0.02$-0.01-100.00%Miss-300.0%
    Jun 20
    		$-0.01N/A+75.00%Beat-125.0%
    Mar 20
    		$0.06$0.02+200.00%Beat+20.0%
    Dec 19
    		$0.02$-0.02+200.00%Beat-50.0%
    Sep 19
    		$0.01$0.02-50.00%Miss-85.7%
    Jun 19
    		$0.04$0.05-20.00%Miss-33.3%
    Mar 19
    		$0.05$0.06-16.67%Miss+600.0%
    Dec 18
    		$0.04$0.05-20.00%Miss+180.0%
    Sep 18
    		$0.07$0.07+0.00%Beat+450.0%
    Jun 18
    		$0.06$0.05+20.00%Beat+250.0%
    Mar 18
    		$-0.01$0.02-150.00%Miss+80.0%
    Dec 17
    		$-0.05$-0.04-25.00%Miss+80.8%
    Sep 17
    		$-0.02N/A+60.00%Beat+75.0%
    Jun 17
    		$-0.04$-0.04+0.00%Beat-
    Mar 17
    		$-0.05$-0.05+0.00%Beat-
    Dec 16
    		$-0.26$-0.07-271.43%Miss-
    Sep 16
    		$-0.08$-0.08+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio231.69EV/EBITDA338.61x
    Price/FCF223.45xFCF Yield0.45%
    Profitability
    Profit Margin54.30%Operating Margin5.96%
    ROE12.80%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio9.69xQuick Ratio7.14x
    Trading Statistics
    Beta1.90Avg Volume683.27K
    52-Week High$38.1052-Week Low$17.86

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$36.75
    SMA 20$35.63
    SMA 50$31.61
    SMA 200$25.23
    EMA 10$36.54
    EMA 20$35.42
    EMA 50$32.29
    EMA 200$26.80

    MACD

    Line: 1.63Signal: 1.75Hist: -0.12

    ADX

    ADX: 69.2+DI: 31.1-DI: 9.4

    Aroon & PSAR

    Aroon Up72.0
    Aroon DownN/A
    PSAR$38.06

    Bollinger Bands

    Upper Band$38.40
    Lower Band$32.86
    %B Position1556%(Upper)
    Band Width0.76

    RSI (14-Day)

    Overbought
    70.1

    Momentum Oscillators

    Stoch %K69.1
    Stoch %D72.4
    Williams %R-28.0
    ROC (10d)4.6%
    Momentum1.62
    CCI (20d)65.1
    MFI (14d)71.6

    Volatility Measures

    ATR (14d)$1.03(2.8%)
    StdDev (20d)1.39
    Hist Vol24.7%(Moderate)

    Volume Flow

    VWAP$36.74
    OBV13.9M
    AD Line389.8K
    CMF (20d)0.207

    Volume Metrics

    Avg Vol (20d)688.6K
    Vol Ratio1.8x(High)
    VWMA (20d)$36.00

    Pivot Points

    R3$37.79
    R2$37.49
    R1$36.94
    Pivot Point$36.64
    S1$36.09
    S2$35.79
    S3$35.24

    Advanced Oscillators

    TSI47.54
    Ultimate Osc58.4
    KST196.51

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$28.47M$27.50M$18.79M$28.07M$23.44M$22.05M$15.11M$21.39M$19.71M$18.43M$-22,497,000$23.57M
    Cost of Revenue$10.18M$10.00M$6.81M$10.15M$8.20M$7.25M$4.45M$7.40M$6.51M$6.19M$-26,757,000$11.58M
    Gross Profit$18.29M$17.50M$11.98M$17.92M$15.23M$14.80M$10.66M$13.99M$13.21M$12.24M$4.26M$11.99M
    Operating Expenses$16.59M$17.47M$10.63M$18.01M$31.36M$15.30M$10.12M$14.41M$14.51M$15.54M$-18,243,000$27.47M
    R&D$2.96M$2.65M$-66,000$2.71M$1.97M$1.44M$-1,246,000$1.89M$2.03M$2.08M$-6,169,000$3.74M
    SG&A$10.69M$12.21M$10.55M$12.07M$11.23M$11.35M$11.59M$9.33M$9.32M$10.40M$3.60M$10.81M
    Operating Income$1.70M$27,000$1.35M$-89,000$-16,126,000$-499,000$542,000$-418,000$-1,306,000$-3,295,000$22.50M$-15,475,000
    Interest Income$994,000$1.04M$833,000$508,000$684,000$683,000$-71,000$-230,000$-4,399,000$-140,000$-159,000$-449,000
    Interest Expense$0$0$0$0$0$0$73,000$133,000$4.25M$0$0$214,000
    Income Before Tax$2.75M$1.25M$3.36M$703,000$-15,195,000$285,000$469,000$-551,000$-5,559,000$-3,182,000$22.61M$-15,689,000
    Income Tax Expense$-42,351,000$62,000$-173,000$82,000$126,000$14,000$24,000$-80,000$1,000$17,000$-273,000$115,000
    Net Income$45.10M$1.19M$11.07M$621,000$-15,838,000$-448,000$12.46M$-1,703,000$-20,719,000$-10,221,000$-14,957,000$-29,132,000
    EBITDA$2.49M$784,000$2.91M$1.30M$-14,697,000$881,000$2.18M$1.91M$1.07M$-946,000$24.93M$-12,272,000
    EBIT$1.76M$207,000$2.53M$195,000$-15,879,000$-398,000$540,000$-321,000$-1,160,000$-3,042,000$22.77M$-15,240,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BLFS

    Government Contracts

    Gov Obligations (TTM)
    $23680
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    N/A

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N90025P00614Department of Health and Human ServicesNational Institutes of Health$23680Aug 6, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    BioLife Solutions (NASDAQ:BLFS) Reaches New 52-Week High - Still a Buy?

    BioLife Solutions (NASDAQ:BLFS) recently reached a new 52-week high of $38.10, with a market capitalization of $1.86 billion, despite analysts maintaining a "Hold" rating and an average price target of $31.38. The company reported a significant earnings beat of $0.91 per share against an estimate of $0.03, with revenues of $28.47 million. Institutional investors hold a substantial 93.24% of the stock, with the California State Teachers’ Retirement System notably increasing its position.

    MarketBeat•8/24/26•
    Neutral

    238,521 Shares in BioLife Solutions, Inc. $BLFS Acquired by Ranger Investment Management L.P.

    Ranger Investment Management L.P. acquired a new position of 238,521 shares in BioLife Solutions, Inc. (NASDAQ:BLFS) valued at approximately $6.7 million during the second quarter, representing 0.49% of the company's stock. Other institutional investors also adjusted their holdings, contributing to institutional ownership of 93.24%. Despite opening near its 52-week high, BioLife Solutions holds a consensus "Hold" rating from analysts with an average price target of $31.38, following several recent downgrades.

    MarketBeat•8/24/26•
    Somewhat-Bullish

    Bank of America Corp DE Increases Stake in BioLife Solutions, Inc. $BLFS

    Bank of America Corp DE significantly increased its stake in BioLife Solutions, Inc. (NASDAQ:BLFS) by 73.4% in the first quarter, now owning 904,103 shares valued at approximately $17.25 million. Other institutional investors also adjusted their positions in the medical equipment provider, which recently reported strong quarterly earnings, beating consensus estimates. Despite several analyst downgrades to "Hold," institutional investors collectively hold 93.24% of BLFS shares.

    MarketBeat•8/21/26•
    Somewhat-Bullish

    Summit Creek Advisors LLC Acquires New Position in BioLife Solutions, Inc. $BLFS

    Summit Creek Advisors LLC has acquired a new position in BioLife Solutions, Inc. (NASDAQ:BLFS) during the second quarter, purchasing 180,544 shares valued at approximately $5.1 million, making BLFS its 28th largest position. Institutional investors and hedge funds collectively own 93.24% of the company, though analyst sentiment remains mixed with an average "Hold" rating. BioLife Solutions recently reported strong quarterly EPS of $0.91, significantly exceeding estimates, while facing insider selling from a major shareholder.

    MarketBeat•8/19/26•
    Neutral

    Diamond Hill Capital Management LLC Investment Advisor Acquires New Stake in BioLife Solutions, Inc. $BLFS

    Diamond Hill Capital Management LLC Investment Advisor has acquired a new stake of 153,887 shares in BioLife Solutions, Inc. (NASDAQ:BLFS), valued at approximately $4.35 million. This purchase represents 0.31% of BioLife Solutions, with institutional investors now owning 93.24% of the company. Despite BioLife Solutions beating analysts' EPS and revenue estimates in its latest quarterly report, the consensus analyst rating for the stock has shifted to "Hold" with a target price of $31.38.

    MarketBeat•8/18/26•
    Neutral

    Frequently Asked Questions About BLFS

    Does BLFS pay dividends?
    BioLife Solutions Inc (BLFS) does not currently pay a regular dividend.
    What is BLFS's P/E ratio?
    BioLife Solutions Inc has a price-to-earnings (P/E) ratio of 231.69.
    What is BLFS's market cap?
    BioLife Solutions Inc (BLFS) has a market capitalization of $1.78B with a current stock price of $37.07.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In